Clinical Trial Update: A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and effectiveness of ELAPR002f Injectable Gel in adults with atrophic acne scars, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne

Drugs mentioned

• ELAPR002f Injectable Gel

Snippet

Sponsor: AbbVie | Conditions: Acne Scars | Phase 3 | Status: RECRUITING